Severe Knee Osteoarthritis and a High BMI: When Conservative Management Has Been Enough
He has failed NSAIDs, one injection, and physical therapy, and his function keeps declining. His BMI sits above the threshold some surgical programs use informally, raising a real question of what more conservative management is actually still supposed to accomplish.
Arthur P., 70, spends most weekday mornings at the kitchen table restoring old transistor radios he picks up at estate sales, a hobby that took over the back den two retirements ago and shows no sign of slowing down. Six years into that retirement, his right knee has taken over more and more of what used to be ordinary life around the same house — he can no longer manage a full flight of stairs without stopping partway, and most nights the pain wakes him at least once, usually more. His osteoarthritis is severe by imaging, and he has genuinely tried the standard conservative pathway: an oral NSAID, one corticosteroid injection that helped for a few weeks and then wore off completely, and a full twelve-week course of structured physical therapy that improved his strength without meaningfully touching his pain. A structured weight-management program, which he has attended consistently rather than sporadically, has produced an eight-pound loss over six months — real progress, honestly reported, and still well short of what would move his BMI of 38 into a range some surgical programs treat as a more comfortable starting point for an elective joint replacement.
The pivot the group is actually arguing isn't about surgical technique or his individual operative risk calculation — that's a decision for a surgical team to make directly, with its own more detailed workup. It's about whether continued conservative management, at this point, is still doing what conservative management is supposed to do, or whether it has become a holding pattern that delays a referral he has, by most reasonable readings of his own history, already earned. Every additional month of unaddressed severe symptomatic disease carries a real cost of its own — further deconditioning, disrupted sleep, and a cumulative NSAID exposure that isn't free either — and that cost doesn't stop accruing just because a referral hasn't been made yet.
Whether conservative management has already done its job
Arthur has done everything conservative management usually asks of a patient before referral — an NSAID trial, one injection, a full structured physical therapy course, and honest, ongoing effort at weight loss, even if the number on the scale hasn't moved as much as anyone would like.
Meanwhile he's lost real function and real sleep for six years and counting. And I'd hold you to your own number: the AAOS threshold is 35, but the cutoff most programs actually defer on is 40, and Arthur is at 38 — above the line where risk starts climbing, below the line where anyone would ordinarily refuse to operate. He's being managed as though he were over a bar he isn't over.
I don't think asking him to hit a specific weight target before he's even seen by a surgeon is medically neutral — every additional month of this is its own accruing cost, not a pause button.
I'm not raising his BMI as an arbitrary gatekeeping number. When the AAOS reviewed modifiable risk factors for periprosthetic joint infection in its 2019 guideline, obesity was the only one that reached moderate-strength evidence, and every qualifying study put the inflection above a BMI of 35. Infection, wound-healing complications and revision all rise measurably from there. That's real surgical-outcomes data, not a soft preference dressed up as caution.
That's a fair correction and I'll take it — 38 is not 40, and I shouldn't argue as if it were. What I'd say instead is that the 40 figure is an institutional convention rather than an evidence threshold, and the evidence line genuinely is behind him. There's also a practical piece here: if I see him now, I'm likely to say some of the same things being said in this room, just later and after he's built up an expectation that a referral means a scheduled surgery date. Using this time for a real, supported push on weight — potentially including newer pharmacologic options — might do more for him than an earlier consultation that circles back to the same recommendation anyway.
I don't think either of you is wrong about your own piece of this, but I don't hear a plan with an actual endpoint in either position — just 'refer now' or 'wait, but for how long and toward what specific target.'
Refer him now, but ask the surgical team to run its own individualized risk assessment as part of that referral — which may very reasonably still recommend a bridging weight-loss period, but with a concrete target and timeline set by the team that's actually going to operate, not an open-ended primary-care holding pattern. The problem we should be trying to avoid isn't referring too soon. It's never producing a real decision either way.
Agreed: refer Arthur for a formal surgical evaluation now, with the referral explicitly framed as requesting the surgical team's own individualized risk assessment and, if appropriate, a concrete weight-management target and timeline — rather than requiring a specific weight loss be achieved first in primary care before a referral is even made.
Not agreed: what the group should do if the surgical evaluation comes back recommending an extended pre-operative weight-loss period with no clearly bounded timeline of its own. The primary care physician would push back on an open-ended surgical-side delay just as much as an open-ended primary-care one; the orthopedic surgeon noted that some individualized uncertainty at that stage may be unavoidable rather than a sign the referral was premature.